Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
Blog
Register Dashboard
Search
Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
My ScienceOpen

Register Dashboard
Search
206
views
8
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      170
      similar
       All similar
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects

      Published
      conference-abstract
      Author(s):   1 , 2 ,   3
      Publication date (Electronic, pub):
      Publisher: REPO4EU
      Conference name: RExPO23
      Conference date: 25-26 October 2023
      Keywords: Network Medicine, Drug Repositioning, Side-Effects, Cardiovascolar Disease
      Bookmark

            Abstract

            Content

            Author and article information

            Conference
            Publisher: REPO4EU
            Publication date (Electronic, pub): 5 October 2023
            Affiliations
            [1 ] Sapienza, Rome (Italy);
            [2 ] Karolinska Institutet, Stockholm (Sweden) ( https://ror.org/056d84691)
            [3 ] Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (USA) ( https://ror.org/04b6nzv94)
            Author information
            https://orcid.org/0000-0002-9393-2047
            https://orcid.org/0000-0002-1153-8047
            Article
            DOI: 10.58647/REXPO.23022
            SO-VID: d87d3b8d-0203-4bb3-8dbc-ff70131c8258
            Copyright © Authors
            License:

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            Conference name: RExPO23
            Conference number: 2
            Conference location: Stockholm, Sweden
            Conference date: 25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data availability: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            ScienceOpen disciplines: Pharmacology & Pharmaceutical medicine
            Keywords: Network Medicine,Drug Repositioning,Side-Effects,Cardiovascolar Disease

            References

            1. Figtree Gemma A, Broadfoot Keith, Casadei Barbara, Califf Robert, Crea Filippo, Drummond Grant R, Freedman Jane E, Guzik Tomasz J, Harrison David, Hausenloy Derek J, Hill Joseph A, Januzzi James L, Kingwell Bronwyn A, Lam Carolyn S P, MacRae Calum A, Misselwitz Frank, Miura Tetsuji, Ritchie Rebecca H, Tomaszewski Maciej, Wu Joseph C, Xiao Junjie, Zannad Faiez. A call to action for new global approaches to cardiovascular disease drug solutions. European Heart Journal. Vol. 42(15):1464–1475. 2021. Oxford University Press (OUP). [Cross Ref]

            2. McClellan Mark, Brown Nancy, Califf Robert M., Warner John J.. Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. Vol. 139(9)2019. Ovid Technologies (Wolters Kluwer Health). [Cross Ref]

            3. Ashburn Ted T., Thor Karl B.. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery. Vol. 3(8):673–683. 2004. Springer Science and Business Media LLC. [Cross Ref]

            4. Crunkhorn Sarah. Deep learning framework for repurposing drugs. Nature Reviews Drug Discovery. Vol. 20(2)2021. Springer Science and Business Media LLC. [Cross Ref]

            5. Park Kyungsoo. A review of computational drug repurposing. Translational and Clinical Pharmacology. Vol. 27(2)2019. Korean Society for Clinical Pharmacology and Therapeutics. [Cross Ref]

            6. Fiscon Giulia, Paci Paola. SAveRUNNER: an R-based tool for drug repurposing. BMC Bioinformatics. Vol. 22(1)2021. Springer Science and Business Media LLC. [Cross Ref]

            7. Fiscon Giulia, Conte Federica, Farina Lorenzo, Paci Paola. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLOS Computational Biology. Vol. 17(2)2021. Public Library of Science (PLoS). [Cross Ref]

            8. Paci Paola, Fiscon Giulia, Conte Federica, Wang Rui-Sheng, Handy Diane E., Farina Lorenzo, Loscalzo Joseph. Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects. npj Systems Biology and Applications. Vol. 8(1)2022. Springer Science and Business Media LLC. [Cross Ref]

            Comments

            Comment on this article